The Company sold all of its rights to Ceplene??? in Europe and certain Pacific Rim countries and a portion of its remaining Ceplene??? inventory to Meda AB. Ceplene??? is licensed to MegaPharm Ltd. to market and sell in Israel and EpiCept has retained its rights to Ceplene??? in all other countries, including countries in North and South America.